Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis

Acta Tropica

Volumn 99, Issue 1, 2006, Pages 83-87

  d'Ettorre, Gabriella ^a   Ceccarelli, Giancarlo ^a   Carnevalini, Martina ^a   Forcina, Gabriele ^a   Zaffiri, Lorenzo ^a   Massetti, Anna P ^a   Mastroianni, Claudio M ^a   Vullo, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

HIV infection; Interleukin 15; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B; ANTIMONY; CYTOKINE; INTERLEUKIN 15;

GENE EXPRESSION; HEALTH RISK; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNOASSAY; LEISHMANIASIS; PARASITOLOGY;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL INDICATOR; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOLOGICAL PARAMETERS; MALE; RECURRENCE RISK; TREATMENT RESPONSE; VISCERAL LEISHMANIASIS;

ADULT; AMPHOTERICIN B; ANIMALS; ANTIMONY; ANTIPROTOZOAL AGENTS; FEMALE; HIV; HIV INFECTIONS; HUMANS; INTERLEUKIN-15; LEISHMANIA; LEISHMANIASIS, VISCERAL; LONGITUDINAL STUDIES; MALE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33748742369     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2006.08.002     Document Type: Article

References (17)

1. Albrecht H. Leishmaniasis-new perspectives on an underappreciated opportunistic infection. AIDS 12 (1998) 2225-2226
2. Alvar J., Canavate C., Gutierrez-Solar B., Jimenez M., Laguna F., Lopez-Velez R., Molina R., and Moreno J. Leishmania and human immunodeficiency virus co-infection: the first 10 years. Clin. Microbiol. Rev. 10 (1997) 298-319
3. Bacellar O., D'Oliveira Jr. A., Jeronimo S., and Carvalho E.M. IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis. Cytokine 12 (2000) 1228-1231
4. Berman J.D. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24 (1997) 684-703
5. Cerf B.J., Jones T.C., Badaro R., Sampaio D., Tyeixeira R., and Johnson W.D.J. Malnutrition as a risk factor for severe visceral leishmaniasis. J. Infect. Dis. 156 (1987) 1030-1033
6. de la Rosa R., Pineda J.A., Delgado J., Macias J., Morillas F., Martin-Sanchez J., Leal M., Sanchez-Quijano A., and Lissen E. Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in HIV-infected patients. Clin. Infect. Dis. 32 (2001) 633-635
7. de la Rosa R., Pineda J.A., Delgado J., Morillas F., Mira J.A., Sanchez-Quijano A., Leal M., and Lissen E. Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type1-infected patients from Spain in the era of highly active antiretroviral therapy. J. Clin. Microbiol. 40 (2002) 762-767
8. Doherty T.M., Seder R.A., and Sher A. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 156 (1996) 735-741
9. Forcina G., d'Ettorre G., Mastroianni C.M., Carnevalini M., Scorzolini L., Ceccarelli G., D'Agostino C., Lichtner M., Massetti A.P., and Vullo V. Interleukin-15 modulates interferon-gamma and beta-chemokine production in patients with HIV infection: implications for immune-based therapy. Cytokine 25 (2004) 283-290
10. Guerin P.J., Olliaro P., Sundar S., Boelaert M., Croft S.L., Desjeux P., Wasunna M.K., and Bryceson A.D.M. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect. Dis. 2 (2002) 494-501
11. Herwaldt B.L. Leishmaniasis. Lancet 354 (1999) 1191-1199
12. Mastroianni C.M., d'Ettorre G., Forcina G., Corpolongo A., Dell'Isola S., Lichtner M., D'Agostino C., Trinchieri V., Santopadre P., and Vullo V. Long term remission of human immunodeficiency associated visceral leishmaniasis after initiation of potent combination antiretroviral treatment: report of two cases. J. Infect. 40 (2000) 94-96
13. Mastroianni C.M., d'Ettorre G., Forcina G., and Vullo V. Teaching tired T cells to fight HIV: time to test IL-15 for immunotherapy?. Trends Immunol. 25 (2004) 121-125
14. Milano S., Di Bella G., D'Agostino P., Barbera C., Caruso R., La Rosa M., Ferlazzo V., Vitale G., La Russa C., Gambino G., Chiari N., Mansueto S., and Cillari E. IL-15 in human visceral leishmaniasis caused by Leishmania infantum. Clin. Exp. Immunol. 127 (2002) 360-365
15. Murray H.W., Berman J.D., Davies C.R., and Saravia N.G. Advances in leishmaniasis. Lancet 366 (2005) 1561-1577
16. Pintado V., and Lopez-Velez R. HIV-associated visceral leishmaniasis. Clin. Microbiol. Infect. 7 (2001) 291-300
17. Wolday D., Berhe N., Britton S., and Akuffo H. HIV-1 alters T helper cytokines, interleukin-12, and interleukin-18 responses to the protozoan parasite Leishmania donovani. AIDS 14 (2000) 921-929